Pharmacy Law

/Pharmacy Law

Client Alert – The First, But Maybe Not The Last? Feds Convict Insys Execs in Opioid Racketeering Case

In a first of its kind prosecution, the US Department of Justice has successfully tried and convicted several top pharmaceutical executives for crimes related to the marketing and sale of opioids. The founder of Insys Therapeutics Inc. (Insys), John N. Kapoor, and four other former Insys executives were convicted in Massachusetts of a RICO conspiracy [...]

Client Alert – DOJ Criminal Division Releases Guidance on Evaluation of Corporate Compliance Programs

The Criminal Division of the United States Justice Department (DOJ) recently released a guidance document for its prosecutors as an adjunct to the agency’s Justice Manual. The Manual provides direction to prosecutors on the factors they should consider when conducting an investigation into alleged corporate wrongdoing. The adequacy and effectiveness of a corporation’s compliance program [...]

Client Alert – FTC Accuses Surescripts of Anticompetitive Tactics

The Federal Trade Commission (FTC) has filed suit against Surescripts, LLC, (Surescripts) an Arlington, Virginia based information technology company that supports e-prescription, the electronic transmission of prescriptions between health care organizations and pharmacies, as well as general health information exchange of medical records, for unfair competition. CVS Health, Express Scripts, the National Association of Chain [...]

Feds Take Down $1.2 Billion Telemedicine and DME Fraud Scheme

Twenty-four CEOs, COOs, doctors, and others have been charged in a Medicare fraud scheme that cost the federal health care program over $1 billion. Dubbed “Operation Brace Yourself,” the nationwide takedown was led by a task force comprised of members of the FBI, Office of Inspector General – Health and Human Services, (OIG-HHS) along with [...]

FDA Schedules Hearings on Cannabis Regulation

On April 2, 2019, the U.S. Food and Drug Administration issued a public hearing notice and a press release from the Commissioner to announce FDA’s interest in hearing from cannabis-industry stakeholders on the “safety, manufacturing, product quality, marketing, labeling, and sale of products containing cannabis or cannabis-derived compounds.” The hearing is set for May 31, [...]

FisherBroyles Welcomes Health & Pharmacy Law Partner Janna King in Houston

HOUSTON — January 2, 2019 — FisherBroyles, LLP, the first and world’s largest cloud-based law firm partnership, is pleased to announce the addition of Janna King as a partner in the firm’s Houston office and Health & Pharmacy Law practice group. “We are thrilled to welcome Janna to FisherBroyles in our Houston office,” said FisherBroyles’ [...]

Government Achieves Another Round of Convictions in New England Compounding Center Case

In 2012, a nationwide meningitis outbreak caused by contaminated steroids killed 64 people and sickened nearly 800 others. Last week in a federal courthouse in Boston, an owner of the company that started it all, New England Compounding Center (NECC), along with four other employees, were convicted of numerous federal crimes for their roles in [...]

Client Alert – CMS Rule Change Could Cost Medicare Advantage Plans Billions

The Centers for Medicare & Medicaid Services (CMS) has proposed significant rule changes that could potentially cost insurers billions of dollars as CMS takes steps to recover what it contends are improper payments made to Medicare Advantage Organizations (MAOs). In a statement, CMS states that, “the proposed rule would strengthen CMS’s ability to return dollars [...]

RXinsider Thought Leader Videos – What are the risks and consequences of non-compliant data breaches?

As part of a Thought Leader Video Series, Anthony Calamunci and Brian Dickerson were interviewed by RXinsider on the status of the Pharmacy industry.  Each week FisherBroyles has provided access to the industry specific Q&A interview sessions hosted by RXinsider so you can learn what the newest legal and industry issues are and how to [...]

RXinsider Thought Leader Videos – What is the Current State of the Federal Investigation Landscape?

As part of a Thought Leader Video Series, Anthony Calamunci and Brian Dickerson were interviewed by RXinsider on the status of the Pharmacy industry.  Each week FisherBroyles will provide access to the industry specific Q&A interview sessions hosted by RXinsider so you can learn what the newest legal and industry issues are and how to [...]